UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

Neuro-oncology (Charlottesville, Va.), 2014-06, Vol.16 (6), p.829-840

2014

Volltextzugriff (PDF)

Silicone passive sampling used to identify novel dermal chemical exposures of firefighters and assess PPE innovations

International journal of hygiene and environmental health, 2023-03, Vol.248, p.114095-114095, Article 114095

2023

Volltextzugriff (PDF)

T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status

American journal of neuroradiology : AJNR, 2015-12, Vol.36 (12), p.2256-2261

2015

Volltextzugriff (PDF)

JS01.5.A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA. A CERN STUDY

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii7-ii7

2023

Volltextzugriff (PDF)

Print Culture, Agency, and Regionality in the Hand Press Period

1, 2022

Volltextzugriff (PDF)

Doing Middle Leadership Right: A Practical Guide to Leading with Honesty and Integrity in Schools

1, 2022

Volltextzugriff (PDF)

Time, the City, and the Literary Imagination

1, 2020

Volltextzugriff (PDF)

YIA20-006: Preclinical Pediatric MATCH

Journal of the National Comprehensive Cancer Network, 2020-03, Vol.18 (3.5), p.YIA20-006

2020

Volltextzugriff (PDF)

Abstract P6-10-05: A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-10-05

2017

Volltextzugriff (PDF)

OS04.6 DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii8-iii8

2017

Volltextzugriff (PDF)

Therapy of chemotherapy‐induced peripheral neuropathy

British journal of haematology, 2009-04, Vol.145 (1), p.3-14

2009

Volltextzugriff (PDF)

Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)

Annals of oncology, 2016-10, Vol.27, p.vi105-vi105

2016

Volltextzugriff (PDF)

Sound Alignments: Popular Music in Asia's Cold Wars

1, 2021

Volltextzugriff (PDF)

OS1.7 Genomic attributes of tumor evolution and treatment response in diffuse glioma

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii218-iii218

2018

Volltextzugriff (PDF)

Sound Alignments: Popular Music in Asia's Cold Wars

2021

Volltextzugriff (PDF)

Sound Alignments: Popular Music in Asia's Cold Wars

2021

Volltextzugriff (PDF)

NI-74 DYNAMIC CONTRAST ENHANCED (DCE) T1 MRI PERFUSION DIFFERENTIATES PSEUDOPROGRESSION FROM RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v154-v155

2014

Volltextzugriff (PDF)

NI-57 DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v150-v151

2014

Volltextzugriff (PDF)

Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma

JCO precision oncology, 2018 (2), p.1-6

2018

Volltextzugriff (PDF)

Preliminary Data from a Multicenter, Phase II, Randomized, Non-Comparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly-Diagnosed Glioblastoma (GBM) (S45.006)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.S45-S45.006

2012

Volltextzugriff (PDF)

Newborn Screening for Cystic Fibrosis in California

Pediatrics (Evanston), 2015-12, Vol.136 (6), p.1062-1072

2015

Volltextzugriff (PDF)

Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2028-2028

2011

Volltextzugriff (PDF)

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2040-2040

2011

Volltextzugriff (PDF)

Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2069-2069

2011

Volltextzugriff (PDF)

Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2055-2055

2009

Volltextzugriff (PDF)

1 – 25 von 3.340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.369)
Mit Volltextzugriff
(3.084)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

Silicone passive sampling used to identify novel dermal chemical exposures of firefighters and assess PPE innovations

T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status

JS01.5.A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA. A CERN STUDY

Print Culture, Agency, and Regionality in the Hand Press Period

Doing Middle Leadership Right: A Practical Guide to Leading with Honesty and Integrity in Schools

Time, the City, and the Literary Imagination

YIA20-006: Preclinical Pediatric MATCH

Abstract P6-10-05: A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)

OS04.6 DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy

Therapy of chemotherapy‐induced peripheral neuropathy

Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)

Sound Alignments: Popular Music in Asia's Cold Wars

OS1.7 Genomic attributes of tumor evolution and treatment response in diffuse glioma

Sound Alignments: Popular Music in Asia's Cold Wars

Sound Alignments: Popular Music in Asia's Cold Wars

NI-74 DYNAMIC CONTRAST ENHANCED (DCE) T1 MRI PERFUSION DIFFERENTIATES PSEUDOPROGRESSION FROM RECURRENT GLIOBLASTOMA

NI-57 DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma

Preliminary Data from a Multicenter, Phase II, Randomized, Non-Comparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly-Diagnosed Glioblastoma (GBM) (S45.006)

Newborn Screening for Cystic Fibrosis in California

Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM)

Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial

Suchergebnisse filtern